Type I interferons (IFNs) are so-named as a result of they intrude with viral an infection in vertebrate cells. The research of mobile responses to type I IFNs led to the discovery of the JAK-STAT signaling pathway, which additionally governs the response to different cytokine households. We overview right here the end result of viral infections in mice and humans with engineered and inborn deficiencies, respectively, of (i) IFNAR1 or IFNAR2, selectively disrupting responses to type I IFNs, (ii) STAT1, STAT2, and IRF9, additionally impairing mobile responses to type II (for STAT1) and/or III (for STAT1, STAT2, IRF9) IFNs, and (iii) JAK1 and TYK2, additionally impairing mobile responses to cytokines aside from IFNs.
An image is rising of higher redundancy of human type I IFNs for protecting immunity to viruses in pure situations than was initially anticipated. Mouse type I IFNs are important for defense towards a broad vary of viruses in experimental situations. These findings counsel that numerous type I IFN-independent mechanisms of human cell-intrinsic immunity to viruses have but to be found.
Genetic mechanisms and correlational choice construction trait variation in a coral snake mimic
Covariation amongst traits shapes each phenotypic evolution and ecological interactions throughout area and time. However, rampant geographical variation in the energy and route of such correlations could be notably tough to clarify via generalized mechanisms. By integrating inhabitants genomics, surveys of pure historical past collections and spatially express analyses, we examined a number of drivers of trait correlations in a coral snake mimic that reveals exceptional polymorphism in mimetic and non-mimetic color traits.
We discovered that though such traits co-occur extensively throughout area, correlations have been greatest defined by a combination of genetic structure and correlational choice, quite than by any single mechanism. Our findings counsel that spatially complicated trait distributions could also be pushed extra by the easy interplay between a number of processes than by complicated variation in one mechanism alone. These interactions are notably vital in mimicry techniques, which continuously generate hanging geographical variation and genetic correlations amongst color sample traits.
Evaluating the function of GSTP1 genetic polymorphism (rs1695, 313A>G) as a predictor in cyclophosphamide-induced toxicities
The affiliation between Glutathione S-transferase Pi 1(GSTP1) genetic polymorphism (rs1695, 313A>G) and cyclophosphamide-induced toxicities has been broadly investigated in earlier research, nonetheless, the outcomes have been inconsistent. This research was carried out to additional elucidate the affiliation.A complete search was performed in PubMed, Embase, Web of Science, China National Knowledge Infrastructure, and Wan Fang database as much as January 5, 2020. Risk ratios (RRs) and 95% confidence intervals (95% CIs) have been used to estimate the affiliation between GSTP1 rs1695 polymorphism and cyclophosphamide-induced hemotoxicity, gastrointestinal toxicity, an infection, and neurotoxicity.A complete of 13 research have been finally included.
Compared with the GSTP1 rs1695 AA genotype carriers, sufferers with AG and GG genotypes had an elevated threat of cyclophosphamide-induced gastrointestinal toxicity (RR, 1.61; 95% CI, 1.18-2.19; P = .003) and an infection (RR, 1.57; 95% CI, 1.00-2.48; P = .05) in the total inhabitants. In the subgroup analyses, there have been vital associations between GSTP1 rs1695 polymorphism and the threat of cyclophosphamide-induced myelosuppression (RR, 2.10; 95% CI, 1.60-2.76; P < .00001), gastrointestinal toxicity (RR, 1.77; 95%CI, 1.25-2.53; P = .001), and an infection (RR, 2.01; 95% CI, 1.14-3.54; P = .02) in systemic lupus erythematosus (SLE) or lupus nephritis syndrome sufferers, however not in most cancers sufferers.
Our outcomes confirmed a necessary function for the GSTP1 rs1695 polymorphism in the prediction of cyclophosphamide-induced myelosuppression, gastrointestinal toxicity, and an infection in SLE or lupus nephritis syndrome sufferers. More research are essential to validate our findings in the future.
Genetic relationships amongst rhizopine-producing Rhizobium strains
Chromosomal and symbiosis-related genotypes of rhizopine-producing and non-producing isolates of Rhizobium meliloti and Rhizobium leguminosarum have been examined by multilocus enzyme electrophoresis and RFLP. The distribution of rhizopine manufacturing in each species was discovered to be unbiased of host genotype. Conversely, rhizopine manufacturing was related with specific symbiotic plasmid varieties.
This affiliation could clarify the noticed distribution of rhizopine manufacturing in R. leguminosarum and R. meliloti. Rhizopine synthesis (mos) genes confirmed higher sequence divergence than rhizopine catabolism (moc) genes in each R. meliloti and R. leguminosarum. Furthermore, mos and moc genes have been much less divergent in R. leguminosarum than R. meliloti, suggesting a newer evolution in the former species.
The Polymorphism Analyses of Short Tandem Repeats as a Basis for Understanding the Genetic Characteristics of the Guanzhong Han Population
The brief tandem repeat (STR) loci are polymorphic markers in the mixed DNA index system (CODIS) and non-CODIS STR loci. Due to the extremely polymorphic attribute of STR loci, they’re fashionable and broadly used in forensic DNA typing laboratories. In this research, 22 STR loci (1 CODIS, 21 non-CODIS STR loci) and an Amelogenin locus have been genotyped and analyzed in 590 unrelated people of the Guanzhong Han inhabitants. None of the 22 STR loci deviated from the Hardy-Weinberg equilibrium, and all the loci have been in the linkage equilibrium state.
We noticed 247 alleles, and the corresponding allelic frequencies ranged from 0.0008 to 0.3695 in the Guanzhong Han inhabitants. The mixed energy of discrimination and the cumulative exclusion likelihood was 0.999 999 999 999 999 999 999 999 999 346 36 and 0.999 999 999 709 74, respectively. The outcomes together with Nei’s D A genetic distance, multidimensional scaling evaluation, and principal part evaluation confirmed that the Guanzhong Han inhabitants has nearer genetic affinities with Northern Han, Chengdu Han, and Xinjiang Hui teams from China primarily based on allelic frequencies of 15 overlapped STR loci from Guanzhong Han and 13 reference teams.
 SCHIP1 antibody |
|||
| 10R-7161 | Fitzgerald | 100 ul | EUR 726 |
|
Description: Mouse monoclonal SCHIP1 antibody |
|||
SCHIP1 antibody |
|||
| 10R-7162 | Fitzgerald | 100 ul | EUR 691 |
|
Description: Mouse monoclonal SCHIP1 antibody |
|||
SCHIP1 antibody |
|||
| 10R-7163 | Fitzgerald | 100 ul | EUR 691 |
|
Description: Mouse monoclonal SCHIP1 antibody |
|||
SCHIP1 antibody |
|||
| 10R-7165 | Fitzgerald | 100 ul | EUR 691 |
|
Description: Mouse monoclonal SCHIP1 antibody |
|||
 SCHIP1 siRNA |
|||
| 20-abx932593 | Abbexa |
|
|
|
|||
SCHIP1 siRNA |
|||
| 20-abx932594 | Abbexa |
|
|
|
|||
 anti-SCHIP1 |
|||
| YF-PA18665 | Abfrontier | 50 ug | EUR 363 |
|
Description: Mouse polyclonal to SCHIP1 |
|||
 HEK-293T Telomerase Over-Expressing Cell Pellet |
|||
| abx069991-1Pellet | Abbexa | 1 Pellet | EUR 398 |
|
|||
 anti- SCHIP1 antibody |
|||
| FNab07634 | FN Test | 100µg | EUR 548.75 |
|
|||
|
Description: Antibody raised against SCHIP1 |
|||
 SCHIP1 Rabbit pAb |
|||
| A17420-100ul | Abclonal | 100 ul | Ask for price |
SCHIP1 Rabbit pAb |
|||
| A17420-200ul | Abclonal | 200 ul | Ask for price |
SCHIP1 Rabbit pAb |
|||
| A17420-20ul | Abclonal | 20 ul | Ask for price |
SCHIP1 Rabbit pAb |
|||
| A17420-50ul | Abclonal | 50 ul | EUR 384 |
 SCHIP1 cloning plasmid |
|||
| CSB-CL878951HU-10ug | Cusabio | 10ug | EUR 233 |
|
|||
|
Description: A cloning plasmid for the SCHIP1 gene. |
|||
 Anti-SCHIP1 antibody |
|||
| PAab07634 | Lifescience Market | 100 ug | EUR 386 |
Anti-SCHIP1 antibody |
|||
| STJ119541 | St John's Laboratory | 50 µl | EUR 393 |
|
Description: NA |
|||
 Bluing Reagent |
|||
| BRT030 | ScyTek Laboratories | 30 ml | EUR 60 |
Bluing Reagent |
|||
| BRT125 | ScyTek Laboratories | 125 ml | EUR 63 |
Bluing Reagent |
|||
| BRT3800 | ScyTek Laboratories | 1 Gal. | EUR 184 |
Bluing Reagent |
|||
| BRT500 | ScyTek Laboratories | 500 ml | EUR 76 |
Bluing Reagent |
|||
| BRT999 | ScyTek Laboratories | 1000 ml | EUR 88 |
 Beaucage reagent |
|||
| HY-100951 | MedChemExpress | 10mM/1mL | EUR 126 |
 BOP reagent |
|||
| A7015-100000 | ApexBio | 100 g | EUR 200 |
|
Description: A peptide coupling reagent. Can be used in the preparation of phenyl esters of amino acids which have been shown to be valuable as blocked derivatives of amino acids in the field of peptide synthesis. |
|||
BOP reagent |
|||
| A7015-25000 | ApexBio | 25 g | EUR 113 |
|
Description: A peptide coupling reagent. Can be used in the preparation of phenyl esters of amino acids which have been shown to be valuable as blocked derivatives of amino acids in the field of peptide synthesis. |
|||
BOP reagent |
|||
| 5-02141 | CHI Scientific | 25g | Ask for price |
BOP reagent |
|||
| 5-02142 | CHI Scientific | 100g | Ask for price |
 Chymase reagent |
|||
| 30C-CP1129 | Fitzgerald | 5 units | EUR 2185 |
|
Description: Purified native Human Chymase reagent |
|||
 Traut's Reagent |
|||
| 2330-1000 | Biovision | EUR 349 | |
Traut's Reagent |
|||
| 2330-500 | Biovision | EUR 207 | |
 MTS Reagent |
|||
| 2808-1000 | Biovision | EUR 990 | |
MTS Reagent |
|||
| 2808-250 | Biovision | EUR 365 | |
 MTT Reagent |
|||
| 2809-1G | Biovision | EUR 180 | |
MTT Reagent |
|||
| 2809-5G | Biovision | EUR 544 | |
 Bradford reagent |
|||
| BDE641 | Bio Basic | 100ml | EUR 61.01 |
|
|||
) Polyclonal SCHIP1 Antibody (Center) |
|||
| APR03745G | Leading Biology | 0.1ml | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SCHIP1 (Center). This antibody is tested and proven to work in the following applications: |
|||
 Mouse SCHIP1 shRNA Plasmid |
|||
| 20-abx974064 | Abbexa |
|
|
|
|||
 SCHIP1 ELISA KIT|Human |
|||
| EF002743 | Lifescience Market | 96 Tests | EUR 689 |
 Human SCHIP1 shRNA Plasmid |
|||
| 20-abx959308 | Abbexa |
|
|
|
|||
) SCHIP1 Recombinant Protein (Human) |
|||
| RP027742 | ABM | 100 ug | Ask for price |
) SCHIP1 Recombinant Protein (Rat) |
|||
| RP227642 | ABM | 100 ug | Ask for price |
) SCHIP1 Recombinant Protein (Mouse) |
|||
| RP170228 | ABM | 100 ug | Ask for price |
SCHIP1 Recombinant Protein (Mouse) |
|||
| RP170231 | ABM | 100 ug | Ask for price |
SCHIP1 Recombinant Protein (Mouse) |
|||
| RP170234 | ABM | 100 ug | Ask for price |
 JM109-lysate Antibody |
|||
| abx234439-100ug | Abbexa | 100 ug | EUR 551 |
|
|||
 BL21-lysate Antibody |
|||
| abx230905-100ug | Abbexa | 100 ug | EUR 551 |
|
|||
 DH5a-lysate Antibody |
|||
| abx232362-100ug | Abbexa | 100 ug | EUR 551 |
|
|||
 CMV Cell Lysate |
|||
| 35-1867 | Fitzgerald | 1 mg | EUR 1835 |
|
Description: CMV enriched cell lysate |
|||
 HSV1 Cell Lysate |
|||
| 35-1872 | Fitzgerald | 1 ml | EUR 394 |
|
Description: HSV1 enriched cell lysate |
|||
 HSV2 Cell Lysate |
|||
| 35-1873 | Fitzgerald | 1 ml | EUR 394 |
|
Description: HSV2 enriched cell lysate |
|||
 Arabidopsis Thaliana Lysate |
|||
| 30R-AA023 | Fitzgerald | 150 ug | EUR 156 |
|
Description: Arabidopsis Thaliana Plant Lysate |
|||
 Green Algae Lysate |
|||
| PABL-1306 | Alpha Diagnostics | 50 ug | EUR 164 |
 PhosphoBlocker Blocking Reagent |
|||
| AKR-103 | Cell Biolabs | 1L | EUR 328 |
|
Description: Most commercially available Western blot blockers, such as dry milk or serum, are sufficient to block unreactive sites on the membrane. However, they are not designed to preserve phosphoprotein antigens during blotting. Our PhosphoBLOCKER Blocking Reagent provides superior blocking by maximizing signal-to-noise ratio. The PhosphoBLOCKER reagent particluarly excels with very low levels of endogenous phopsphoproteins. |
|||
PhosphoBlocker Blocking Reagent |
|||
| AKR-104 | Cell Biolabs | 4L | EUR 711 |
|
Description: Most commercially available Western blot blockers, such as dry milk or serum, are sufficient to block unreactive sites on the membrane. However, they are not designed to preserve phosphoprotein antigens during blotting. Our PhosphoBLOCKER Blocking Reagent provides superior blocking by maximizing signal-to-noise ratio. The PhosphoBLOCKER reagent particluarly excels with very low levels of endogenous phopsphoproteins. |
|||
 Biolipidure-1002-Reagent |
|||
| Biolipidure-1002-10 | Cusabio | 10mL | EUR 196 |
|
|||
|
Description: The Biolipidure-1002-Reagent is a synthetic amphoteric polymer that can be substituted for BSA in tubidimetric immunoassays. Biolipidure-1002 is an excellent blocker and also enhances assay sensitivity. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-1002-Reagent |
|||
| Biolipidure-1002-100 | Biolipidure | 100mL | EUR 1223 |
|
|||
|
Description: The Biolipidure-1002-Reagent is a synthetic amphoteric polymer that can be substituted for BSA in tubidimetric immunoassays. Biolipidure-1002 is an excellent blocker and also enhances assay sensitivity. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
 Biolipidure-103-Reagent |
|||
| Biolipidure-103-10 | Biolipidure | 10mL | EUR 196 |
|
|||
|
Description: The Biolipidure-103-Reagent is a synthetic amphoteric polymer that can be substituted for BSA. It has been shown to enhance signals in rapid tests, western blots, and other similar immunochromatographic assays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-103-Reagent |
|||
| Biolipidure-103-100 | Biolipidure | 100mL | EUR 1223 |
|
|||
|
Description: The Biolipidure-103-Reagent is a synthetic amphoteric polymer that can be substituted for BSA. It has been shown to enhance signals in rapid tests, western blots, and other similar immunochromatographic assays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
 Biolipidure-1201-Reagent |
|||
| Biolipidure-1201-10 | Biolipidure | 10mL | EUR 196 |
|
|||
|
Description: The Biolipidure-1201 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-1201-Reagent |
|||
| Biolipidure-1201-100 | Biolipidure | 100mL | EUR 1223 |
|
|||
|
Description: The Biolipidure-1201 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
 Biolipidure-1301-Reagent |
|||
| Biolipidure-1301-10 | Biolipidure | 10mL | EUR 196 |
|
|||
|
Description: The Biolipidure-1301 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-1301-Reagent |
|||
| Biolipidure-1301-100 | Biolipidure | 100mL | EUR 1223 |
|
|||
|
Description: The Biolipidure-1301 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
 Biolipidure-203-Reagent |
|||
| Biolipidure-203-10 | Biolipidure | 10mL | EUR 196 |
|
|||
|
Description: The Biolipidure-203 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Biolipidure-203 has been shown to enhance signal strength by improving signal-to-noise in ELISAs, EIAs, and related immunoassays. It also functions as an effective blocker and stabilizer in these assays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-203-Reagent |
|||
| Biolipidure-203-100 | Biolipidure | 100mL | EUR 1223 |
|
|||
|
Description: The Biolipidure-203 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Biolipidure-203 has been shown to enhance signal strength by improving signal-to-noise in ELISAs, EIAs, and related immunoassays. It also functions as an effective blocker and stabilizer in these assays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
 Biolipidure-206-Reagent |
|||
| Biolipidure-206-10 | Biolipidure | 10mL | EUR 196 |
|
|||
|
Description: The Biolipidure-206 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Biolipidure-206 enhances signal strength, functions as an effective blocker, and stabilizes proteins and antibodies in ELISAs, EIAs, and related immunoassays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-206-Reagent |
|||
| Biolipidure-206-100 | Biolipidure | 100mL | EUR 1223 |
|
|||
|
Description: The Biolipidure-206 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Biolipidure-206 enhances signal strength, functions as an effective blocker, and stabilizes proteins and antibodies in ELISAs, EIAs, and related immunoassays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
 Biolipidure-405-Reagent |
|||
| Biolipidure-405-10 | Biolipidure | 10mL | EUR 196 |
|
|||
|
Description: The Biolipidure-405 Reagent is a synthetic anionic polymer that can be used to enhance immunochromatographic assays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-405-Reagent |
|||
| Biolipidure-405-100 | Biolipidure | 100mL | EUR 1223 |
|
|||
|
Description: The Biolipidure-405 Reagent is a synthetic anionic polymer that can be used to enhance immunochromatographic assays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
 Biolipidure-502-Reagent |
|||
| Biolipidure-502-10 | Biolipidure | 10mL | EUR 196 |
|
|||
|
Description: The Biolipidure-502 Reagent is a synthetic cationic polymer. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-502-Reagent |
|||
| Biolipidure-502-100 | Biolipidure | 100mL | EUR 1223 |
|
|||
|
Description: The Biolipidure-502 Reagent is a synthetic cationic polymer. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
 Biolipidure-702-Reagent |
|||
| Biolipidure-702-10 | Biolipidure | 10mL | EUR 196 |
|
|||
|
Description: The Biolipidure-702 Reagent is a synthetic amphoteric polymer. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-702-Reagent |
|||
| Biolipidure-702-100 | Biolipidure | 100mL | EUR 1223 |
|
|||
|
Description: The Biolipidure-702 Reagent is a synthetic amphoteric polymer. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
 Biolipidure-802-Reagent |
|||
| Biolipidure-802-10 | Biolipidure | 10mL | EUR 196 |
|
|||
|
Description: The Biolipidure-802 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Biolipidure-802 generally enhances signal strength, functions as an effective blocker, and stabilizes proteins and antibodies in ELISAs, EIAs, Rapid-test, and related immunoassays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
Biolipidure-802-Reagent |
|||
| Biolipidure-802-100 | Biolipidure | 100mL | EUR 1223 |
|
|||
|
Description: The Biolipidure-802 Reagent is a synthetic amphoteric polymer that can be substituted for BSA. Biolipidure-802 generally enhances signal strength, functions as an effective blocker, and stabilizes proteins and antibodies in ELISAs, EIAs, Rapid-test, and related immunoassays. Applications include: Immunoassays, Western blots, Immunohistochemistry, Turbidimetric assays, Immunochromatography, and Bead based assays. Benefits include: No lot to lot variation, No animal derived materials, Non-specific adsorption suppression, Stabilization of immobilized antibody, Stabilization of enzyme-antibody conjugate, Enzyme-substrate reaction enhancement and aggregation reaction enhancement |
|||
 BCA Reagent, 16ML |
|||
| C144-16ML | Arbor Assays | 16ML | EUR 163 |
) Alcohol, Reagent (70%) |
|||
| EAS500 | ScyTek Laboratories | 500 ml | EUR 79 |
Alcohol, Reagent (70%) |
|||
| EAS999 | ScyTek Laboratories | 1000 ml | EUR 101 |
 Tri-RNA Reagent |
|||
| FATRR-001 | Favorgen | 100ml | EUR 236 |
Tri-RNA Reagent |
|||
| FATRR-002 | Favorgen | 50ml | EUR 176 |
Tri-RNA Reagent |
|||
| FATRR-003 | Favorgen | 450ml | EUR 645 |
 EL Transfection Reagent |
|||
| 20-abx098880 | Abbexa |
|
|
|
|||
 Mycoplasma Prevention Reagent |
|||
| 20-abx098886 | Abbexa |
|
|
|
|||
 Girard's reagent T |
|||
| 20-abx184099 | Abbexa |
|
|
|
|||
 FcR blocking Reagent |
|||
| 20-abx290024 | Abbexa |
|
|
|
|||
 Detection Reagent A |
|||
| abx296004-120ul | Abbexa | 120 ul | EUR 321 |
|
|||
Mycoplasma Prevention Reagent |
|||
| 20-abx298005 | Abbexa |
|
|
|
|||
 HAMA blocking reagent |
|||
| 85R-1001 | Fitzgerald | 1 gram | EUR 1974 |
|
Description: HAMA Blocking Reagent for use in immunoassays such as ELISA |
|||
HAMA blocking reagent |
|||
| 85R-1001P | Fitzgerald | 1 gram | EUR 2190 |
|
Description: HAMA Blocking Reagent for use in immunoassays such as ELISA |
|||
HAMA blocking reagent |
|||
| 85R-1003 | Fitzgerald | 1 gram | EUR 1974 |
|
Description: HAMA Blocking Reagent for use in immunoassays such as Rapid Tests |
|||
HAMA blocking reagent |
|||
| 85R-1014 | Fitzgerald | 50 mg | EUR 192 |
|
Description: HAMA blocking reagent for use in assays specific for clinical false positive samples |
|||
HAMA blocking reagent |
|||
| 85R-1025 | Fitzgerald | 50 mg | EUR 192 |
|
Description: HAMA blocking reagent for use in immunoassays |
|||
HAMA blocking reagent |
|||
| 85R-1026 | Fitzgerald | 50 mg | EUR 192 |
|
Description: HAMA blocking reagent for use in immunoassays |
|||
 Convoy? Transfection Reagent |
|||
| 1110-1ml | ACTGene | EUR 341 | |
 Bradford Dye Reagent |
|||
| 0209R | AthenaES | 100 ml | EUR 131 |
) BSA (Reagent Grade) |
|||
| 30-AB79 | Fitzgerald | 1 kg | EUR 1552 |
|
Description: Reagent Grade Bovine Serum Albumin (99% pure) |
|||
BSA (Reagent Grade) |
|||
| 30-AB81 | Fitzgerald | 200 grams | EUR 476 |
|
Description: Reagent Grade Sulphydryl Blocked BSA (99% pure) |
|||
 Griess Reagent Kit |
|||
| 30100 | Biotium | 1KIT | EUR 149 |
|
Description: Minimum order quantity: 1 unit of 1KIT |
|||
 BODIPY-Acetylene Reagent |
|||
| 2594-1 | Biovision | EUR 207 | |
BODIPY-Acetylene Reagent |
|||
| 2594-5 | Biovision | EUR 675 | |
) Biotin reagent (HRP) |
|||
| 65C-CE0202 | Fitzgerald | 5 mg | EUR 244 |
|
Description: HRP conjugated biotin labelling reagent |
|||
 PureFection Transfection Reagent |
|||
| LV750A-1 | SBI | 1 ml | EUR 359 |
|
|||
 LP4K Transfection Reagent |
|||
| LP4K | GenTarget | 1.0 ml / vial | EUR 304 |
|
Description: Lipid based transfection reagent for large plasmid and multiple plasmid transfection in both adhesive and suspenstion cell types. |
|||
 HighGene transfection reagent |
|||
| RM09014 | Abclonal | 1000μl | EUR 270 |
 TissueDigest Reagent, 20X |
|||
| T101 | Insitus Biotechnologies | 10ml | EUR 210 |
 ExFect2000 Transfection Reagent |
|||
| T202-01 | Vazyme | 0.5 ml | EUR 227 |
ExFect2000 Transfection Reagent |
|||
| T202-02 | Vazyme | 1 ml | EUR 316 |
ExFect2000 Transfection Reagent |
|||
| T202-03 | Vazyme | 5 ml | EUR 1052 |
 Dissociation Reagent, 1ML |
|||
| X017-1ML | Arbor Assays | 1ML | EUR 109 |
 Dissociation Reagent, 25ML |
|||
| X017-25ML | Arbor Assays | 25ML | EUR 258 |
 Dissociation Reagent, 5ML |
|||
| X017-5ML | Arbor Assays | 5ML | EUR 122 |
Dissociation Reagent, 1ML |
|||
| X058-1ML | Arbor Assays | 1ML | EUR 73 |
Dissociation Reagent, 5ML |
|||
| X058-5ML | Arbor Assays | 5ML | EUR 109 |
 n-Heptane Reagent |
|||
| HC5400 | Bio Basic | 1L | EUR 79 |
|
|||
) DTT (Cleland's reagent) |
|||
| DB0058 | Bio Basic | 5g | EUR 84.8 |
|
|||
) DTNB (Ellman's Reagent) |
|||
| DB0113 | Bio Basic | 5g | EUR 97.85 |
|
|||
 Ethyl acetate Reagent |
|||
| EC4600 | Bio Basic | 1L | EUR 79 |
|
|||
 (pORF)) SCHIP1 ORF Vector (Human) (pORF) |
|||
| ORF009248 | ABM | 1.0 ug DNA | EUR 95 |
 (pORF)) Schip1 ORF Vector (Mouse) (pORF) |
|||
| ORF056744 | ABM | 1.0 ug DNA | EUR 506 |
Schip1 ORF Vector (Mouse) (pORF) |
|||
| ORF056745 | ABM | 1.0 ug DNA | EUR 506 |
Schip1 ORF Vector (Mouse) (pORF) |
|||
| ORF056746 | ABM | 1.0 ug DNA | EUR 506 |
 (pORF)) Schip1 ORF Vector (Rat) (pORF) |
|||
| ORF075882 | ABM | 1.0 ug DNA | EUR 506 |
) IQCJ-SCHIP1 Recombinant Protein (Human) |
|||
| RP065874 | ABM | 100 ug | Ask for price |
) IQCJ-SCHIP1 Recombinant Protein (Mouse) |
|||
| RP144110 | ABM | 100 ug | Ask for price |
 (OKCA01504)) SCHIP1 ELISA Kit (Human) (OKCA01504) |
|||
| OKCA01504 | Aviva Systems Biology | 96 Wells | EUR 846 |
|
Description: Description of target: ;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sanadwich ELISA;Sensitivity: 9.77 pg/mL |
|||
 anti- BL21-lysate antibody |
|||
| FNab00905 | FN Test | 100µg | EUR 585 |
|
Description: Antibody raised against BL21-lysate |
|||
 anti- DH5a-lysate antibody |
|||
| FNab02362 | FN Test | 100µg | EUR 585 |
|
|||
|
Description: Antibody raised against DH5a-lysate |
|||
 Human Lung Tumor lysate |
|||
| HTL-1321 | Alpha Diagnostics | 1 mg | EUR 773 |
 Human Brain Tumor lysate |
|||
| HTL-1322 | Alpha Diagnostics | 1 mg | EUR 773 |
 Human Breast Tumor lysate |
|||
| HTL-1323 | Alpha Diagnostics | 1 mg | EUR 773 |
 Human Kidney Tumor lysate |
|||
| HTL-1324 | Alpha Diagnostics | 1 mg | EUR 773 |
 Human Bladder Tumor lysate |
|||
| HTL-1325 | Alpha Diagnostics | 1 mg | EUR 773 |
 Human Cervix Tumor lysate |
|||
| HTL-1326 | Alpha Diagnostics | 100ug | EUR 286 |
 Human Duodenum Tumor lysate |
|||
| HTL-1328 | Alpha Diagnostics | 1 mg | EUR 895 |
 Human Esophagus tumor lysate |
|||
| HTL-1329 | Alpha Diagnostics | 1 mg | EUR 773 |
 Human Liver Tumor lysate |
|||
| HTL-1330 | Alpha Diagnostics | 1 mg | EUR 773 |
 Human Lymphoma Tumor lysate |
|||
| HTL-1331 | Alpha Diagnostics | 1 mg | EUR 773 |
 Human Ovary Tumor lysate |
|||
| HTL-1333 | Alpha Diagnostics | 1 mg | EUR 773 |
 Human Pancreas Tumor lysate |
|||
| HTL-1334 | Alpha Diagnostics | 1 mg | EUR 773 |
 Human Prostate Tumor lysate |
|||
| HTL-1335 | Alpha Diagnostics | 1 mg | EUR 773 |
 Human Rectum Tumor lysate |
|||
| HTL-1336 | Alpha Diagnostics | 1 mg | EUR 773 |
 Human Skin Tumor lysate |
|||
| HTL-1337 | Alpha Diagnostics | 1 mg | EUR 773 |
 Human Spleen Tumor lysate |
|||
| HTL-1339 | Alpha Diagnostics | 1 mg | EUR 773 |
 Human Stomach Tumor lysate |
|||
| HTL-1340 | Alpha Diagnostics | 1 mg | EUR 773 |
 Human Testis Tumor lysate |
|||
| HTL-1381 | Alpha Diagnostics | 1 mg | EUR 773 |
 Human Thymoma Tumor lysate |
|||
| HTL-1382 | Alpha Diagnostics | 1 mg | EUR 773 |
 Human Thyroid Tumor lysate |
|||
| HTL-1383 | Alpha Diagnostics | 1 mg | EUR 773 |
 Human Uterus Tumor lysate |
|||
| HTL-1384 | Alpha Diagnostics | 1 mg | EUR 773 |
 CHO Lysate Antigen Concentrate |
|||
| F018H | Cygnus Technologies | 200 ul | EUR 604 |
|
|||
|
Description: CHO Lysate Antigen Concentrate by Cygnus Technologies is available in Europe via Gentaur. |
|||
CHO Lysate Antigen Concentrate |
|||
| F018R | Cygnus Technologies | 1 ml | EUR 6225 |
|
|||
|
Description: CHO Lysate Antigen Concentrate by Cygnus Technologies is available in Europe via Gentaur. |
|||
 anti- JM109-lysate antibody |
|||
| FNab04439 | FN Test | 100µg | EUR 585 |
|
|||
|
Description: Antibody raised against JM109-lysate |
|||
-lysate Antibody) BL21(DE3)-lysate Antibody |
|||
| abx230903-100ug | Abbexa | 100 ug | EUR 551 |
|
|||
 -lysate Antibody) BL21(plysS) -lysate Antibody |
|||
| abx230904-100ug | Abbexa | 100 ug | EUR 551 |
|
|||
 Human Brain Tissue Lysate |
|||
| 30R-AB017 | Fitzgerald | 150 ug | EUR 273 |
|
Description: Fresh tissue lysate isolated from human brain |
|||
 Chicken Liver Tissue Lysate |
|||
| 30R-AC011 | Fitzgerald | 150 ug | EUR 192 |
|
Description: Freshly prepared tissue lysate isolated from liver of normal chicken |
|||
 Human Cerebellum Tissue Lysate |
|||
| 30R-AC058 | Fitzgerald | 150 ug | EUR 290 |
|
Description: Freshly prepared tissue lysate isolated from cerebellum of human brain |
|||
 Human Hippocampus Tissue Lysate |
|||
| 30R-AH | Fitzgerald | 150 ug | EUR 273 |
|
Description: Isolated Human Hippocampus Tissue Lysate |
|||
 Human Heart Tissue Lysate |
|||
| 30R-AH049 | Fitzgerald | 150 ug | EUR 534 |
|
Description: Fresh tissue lysate isolated from human heart |
|||
 Human Kidney Tissue Lysate |
|||
| 30R-AK003 | Fitzgerald | 150 ug | EUR 219 |
|
Description: Fresh tissue lysate isolated from human kidney |
|||
 Rabbit Liver Tissue Lysate |
|||
| 30R-AL003 | Fitzgerald | 150 ug | EUR 252 |
|
Description: Fresh tissue lysate prepared from rabbit liver |
|||
 Human Lung Tissue Lysate |
|||
| 30R-AL006 | Fitzgerald | 150 ug | EUR 219 |
|
Description: Fresh tissue lysate isolated from human lung |
|||
 Human Midbrain Tissue Lysate |
|||
| 30R-AM011 | Fitzgerald | 150 ug | EUR 257 |
|
Description: Fresh tissue lysate isolated from the midbrain of human brain |
|||
 Human Pancreas Tissue Lysate |
|||
| 30R-AP030 | Fitzgerald | 150 ug | EUR 219 |
|
Description: Fresh tissue lysate isolated from human pancreas |
|||
 Human Prostate Tissue Lysate |
|||
| 30R-AP031 | Fitzgerald | 150 ug | EUR 219 |
|
Description: Fresh tissue lysate prepared from normal human prostate |
|||
 Human Pons Tissue Lysate |
|||
| 30R-AP033 | Fitzgerald | 150 ug | EUR 235 |
|
Description: Fresh tissue lysate isolated from the pons of human brain |
|||
 Human Posterior Cortex Lysate |
|||
| 30R-AP034 | Fitzgerald | 150 ug | EUR 235 |
|
Description: Fresh tissue lysate isolated from the posterior cortex of human brain |
|||
 Rat Retina Tissue Lysate |
|||
| 30R-AR005 | Fitzgerald | 150 ug | EUR 267 |
|
Description: Fresh tissue lysate prepared from the retina of rat eye |
|||
 Human Striatum Tissue Lysate |
|||
| 30R-AS030 | Fitzgerald | 150 ug | EUR 327 |
|
Description: Fresh tissue lysate isolated from the striatum of human brain |
|||
 Human Stomach Tissue Lysate |
|||
| 30R-AS039 | Fitzgerald | 150 ug | EUR 219 |
|
Description: Fresh tissue lysate isolated from human stomach |
|||
 Human Thalamus Tissue Lysate |
|||
| 30R-AT053 | Fitzgerald | 150 ug | EUR 235 |
|
Description: Fresh tissue lysate isolated from the thalamus of human brain |
|||
) Jurkat cell Lysate (untreated) |
|||
| 2401-100 | Biovision | EUR 185 | |
 JNK Activated Cell Lysate |
|||
| 7032-1 | Biovision | EUR 316 | |
 Akt Activated Cell Lysate |
|||
| 7036-1 | Biovision | EUR 316 | |
 Anti-BL21-lysate antibody |
|||
| PAab00905 | Lifescience Market | 100 ug | EUR 412 |
 Anti-DH5a-lysate antibody |
|||
| PAab02362 | Lifescience Market | 100 ug | EUR 412 |
 Anti-JM109-lysate antibody |
|||
| PAab04439 | Lifescience Market | 100 ug | EUR 412 |
 Rat Brain Tissue Lysate |
|||
| LYSATE0002 | BosterBio | 200ug | EUR 150 |
|
Description: This cell lysate is prepared from Rat Brain Tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
 Rat Liver Tissue Lysate |
|||
| LYSATE0003 | BosterBio | 200ug | EUR 150 |
|
Description: This cell lysate is prepared from rat liver tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
 Rat Lung Tissue Lysate |
|||
| LYSATE0004 | BosterBio | 200ug | EUR 150 |
|
Description: This cell lysate is prepared from rat lung tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
 Rat Testis Tissue Lysate |
|||
| LYSATE0005 | BosterBio | 200ug | EUR 150 |
|
Description: This cell lysate is prepared from rat testis tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
 Rat Kidney Tissue Lysate |
|||
| LYSATE0006 | BosterBio | 200ug | EUR 150 |
|
Description: This cell lysate is prepared from rat kidney tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
 Rat Spleen Tissue Lysate |
|||
| LYSATE0007 | BosterBio | 200ug | EUR 150 |
|
Description: This cell lysate is prepared from rat spleen tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
 Rat Thymus Tissue Lysate |
|||
| LYSATE0008 | BosterBio | 200ug | EUR 150 |
|
Description: This cell lysate is prepared from rat thymus tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
 Rat Heart Tissue Lysate |
|||
| LYSATE0009 | BosterBio | 200ug | EUR 150 |
|
Description: This cell lysate is prepared from rat heart tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
 Rat Ovary Tissue Lysate |
|||
| LYSATE0011 | BosterBio | 200ug | EUR 150 |
|
Description: This cell lysate is prepared from rat ovary tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
 Mouse Brain Tissue Lysate |
|||
| LYSATE0012 | BosterBio | 200ug | EUR 150 |
|
Description: This cell lysate is prepared from mouse brain tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
 Mouse Liver Tissue Lysate |
|||
| LYSATE0013 | BosterBio | 200ug | EUR 150 |
|
Description: This cell lysate is prepared from mouse liver tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
 Mouse Testis Tissue Lysate |
|||
| LYSATE0014 | BosterBio | 200ug | EUR 150 |
|
Description: This cell lysate is prepared from mouse testis tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
 Mouse Ovary Tissue Lysate |
|||
| LYSATE0015 | BosterBio | 200ug | EUR 150 |
|
Description: This cell lysate is prepared from mouse ovary tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
 Mouse Kidney Tissue Lysate |
|||
| LYSATE0016 | BosterBio | 200ug | EUR 150 |
|
Description: This cell lysate is prepared from mouse kidney tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
 Mouse Spleen Tissue Lysate |
|||
| LYSATE0017 | BosterBio | 200ug | EUR 150 |
|
Description: This cell lysate is prepared from mouse spleen tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
 Mouse Lung Tissue Lysate |
|||
| LYSATE0018 | BosterBio | 200ug | EUR 150 |
|
Description: This cell lysate is prepared from mouse lung tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
 Mouse Thymus Tissue Lysate |
|||
| LYSATE0019 | BosterBio | 200ug | EUR 150 |
|
Description: This cell lysate is prepared from mouse thymus tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
 Mouse Heart Tissue Lysate |
|||
| LYSATE0020 | BosterBio | 200ug | EUR 150 |
|
Description: This cell lysate is prepared from mouse heart tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
 Human Placenta Tissue Lysate |
|||
| LYSATE0022 | BosterBio | 200ug | EUR 150 |
|
Description: This cell lysate is prepared from human placenta tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
 Human U87 Cell Lysate |
|||
| LYSATE0041 | BosterBio | 200ug | EUR 150 |
|
Description: This cell lysate is prepared from human U87 using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
 Lysate) Trout Liver (Normal) Lysate |
|||
| THUL-50 | Alpha Diagnostics | 50 ug | EUR 213 |
 EZ Cap? Reagent AG |
|||
| B8176-.01 | ApexBio | 10 µl (100 mM) | EUR 308 |
|
Description: EZ Cap Reagent AG is a co-transcriptional capping reagent for in vitro transcription of 5? capped mRNA which would result in a Cap 1 structure. Cap AG has shown to provide up to 98% capping efficiency in literatures.EZ Cap AG requires an AG initiator. |
|||
The current outcomes indicated that Microreader™ 23sp ID equipment included extremely polymorphic loci, and it might be effectively used for particular person identification, paternity testing, and inhabitants genetics in the Guanzhong Han inhabitants.